Induction of retinoid resistance by all-trans retinoic acid in acute promyelocytic leukemia after remission.

Acute promyelocytic leukemia (APL) results from a malignant process that leads to the accumulation in the blood and the bone marrow of myeloid precursor cells characterized by an abnormal behavior and a differentiation arrest. It aroused considerable interest well beyond the hematologic field during the last five years since APL has two unique features i) the remission of the disease obtained with all-trans retinoic acid (ATRA) treatment ii) the presence in APL blasts of an abnormal protein, the promyelocytic myeloid leukemia/retinoic acid receptor (PML/RAR alpha) protein. APL is characterized cytogenetically by a t(15;17) translocation which involves both the PML gene on chromosome 15 and the RAR alpha gene on chromosome 17 and gives rise to the PML/RAR alpha fusion protein.

[1]  P. Fenaux,et al.  Hematopoietic growth factor expression and ATRA sensitivity in acute promyelocytic blast cells , 1994 .

[2]  R. Gallagher,et al.  Retinoic acid-resistant HL-60 cells exclusively contain mutant retinoic acid receptor-alpha. , 1994, Blood.

[3]  P. Pelicci,et al.  Clinical relevance of the PML/RAR-a gene rearrangement in acute promyelocytic leukaemia. , 1994, Leukemia & lymphoma.

[4]  P. Fenaux,et al.  Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group , 1993 .

[5]  P. Fenaux,et al.  Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cells. , 1993, Blood.

[6]  R. Warrell.  Retinoid resistance in acute promyelocytic leukemia: new mechanisms, strategies, and implications. , 1993, Blood.

[7]  H. de Thé,et al.  PML protein expression in hematopoietic and acute promyelocytic leukemia cells. , 1993, Blood.

[8]  P. Pelicci,et al.  Occurrence of resistance to retinoic acid in the acute promyelocytic leukemia cell line NB4 is associated with altered expression of the pml/RAR alpha protein. , 1993, Blood.

[9]  R. Berger,et al.  A retinoid acid 'resistant' t(15;17) acute promyelocytic leukemia cell line: isolation, morphological, immunological, and molecular features. , 1992, Leukemia.

[10]  T. Lister,et al.  Diagnosis of acute promyelocytic leukaemia by RT‐PCR: detection of PML‐RARA and RARA‐PML fusion transcripts , 1992, British journal of haematology.

[11]  L. Gudas,et al.  The level of CRABP-I expression influences the amounts and types of all-trans-retinoic acid metabolites in F9 teratocarcinoma stem cells. , 1992, The Journal of biological chemistry.

[12]  K. Robertson,et al.  Retinoic acid-resistant HL-60R cells harbor a point mutation in the retinoic acid receptor ligand-binding domain that confers dominant negative activity. , 1992, Blood.

[13]  P. Chambon,et al.  All-trans and 9-cis retinoic acid induction of CRABPII transcription is mediated by RAR-RXR heterodimers bound to DR1 and DR2 repeated motifs , 1992, Cell.

[14]  P. Chambon,et al.  Human skin levels of retinoic acid and cytochrome P-450-derived 4-hydroxyretinoic acid after topical application of retinoic acid in vivo compared to concentrations required to stimulate retinoic acid receptor-mediated transcription in vitro. , 1992, The Journal of clinical investigation.

[15]  E. Solomon,et al.  Molecular analysis of the t(15;17) translocation in acute promyelocytic leukaemia. , 1992, Bailliere's clinical haematology.

[16]  C. Bowden,et al.  Experimental studies with liarozole (R 75 251): An antitumoral agent which inhibits retinoic acid breakdown , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[17]  K. Umesono,et al.  Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors , 1992, Nature.

[18]  R. Warrell,et al.  The "Retinoic Acid Syndrome" in Acute Promyelocytic Leukemia , 1992, Annals of Internal Medicine.

[19]  W. Bollag,et al.  Retinoids in cancer prevention and therapy. , 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

[20]  P G Pelicci,et al.  Characterization of the PML-RAR alpha chimeric product of the acute promyelocytic leukemia-specific t(15;17) translocation. , 1992, Cancer research.

[21]  C. Chomienne,et al.  Induction of retinoic acid-binding protein in normal and malignant human myeloid cells by retinoic acid in acute promyelocytic leukemia patients. , 1992, Cancer research.

[22]  D. Winfield,et al.  All-trans retinoic acid and side-effects , 1992, The Lancet.

[23]  R. Warrell,et al.  Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia. , 1992, Cancer research.

[24]  F. Lo Coco,et al.  Genomic variability and alternative splicing generate multiple PML/RAR alpha transcripts that encode aberrant PML proteins and PML/RAR alpha isoforms in acute promyelocytic leukaemia. , 1992, The EMBO journal.

[25]  R. Evans,et al.  Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. , 1992, Genes & development.

[26]  D. Darling,et al.  Triiodothyronine (T3) decreases binding to DNA by T3-receptor homodimers but not receptor-auxiliary protein heterodimers. , 1992, The Journal of biological chemistry.

[27]  M. Pfahl,et al.  Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors , 1992, Nature.

[28]  Philippe Kastner,et al.  Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently , 1992, Cell.

[29]  E. Dmitrovsky,et al.  Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia. , 1992, Blood.

[30]  C. Glass,et al.  RXRβ: A coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements , 1991, Cell.

[31]  A. Agadir,et al.  Pharmacokinetics of oral all-trans retinoic acid in patients with acute promyelocytic leukemia. , 1991, Leukemia.

[32]  H. de Thé,et al.  All-trans retinoic acid modulates the retinoic acid receptor-alpha in promyelocytic cells. , 1991, The Journal of clinical investigation.

[33]  M. Pfahl,et al.  6'-substituted naphthalene-2-carboxylic acid analogs, a new class of retinoic acid receptor subtype-specific ligands. , 1991, Biochemical and biophysical research communications.

[34]  Zi X. Chen,et al.  A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients. , 1991, Blood.

[35]  James T. Elder,et al.  Molecular cloning of two human cellular retinoic acid-binding proteins (CRABP). Retinoic acid-induced expression of CRABP-II but not CRABP-I in adult human skin in vivo and in skin fibroblasts in vitro. , 1991, The Journal of biological chemistry.

[36]  J. L. Napoli,et al.  Expression of cellular retinoic acid binding protein (CRABP) in Escherichia coli. Characterization and evidence that holo-CRABP is a substrate in retinoic acid metabolism. , 1991, The Journal of biological chemistry.

[37]  Christine Chomienne,et al.  The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR , 1991, Cell.

[38]  K. Umesono,et al.  Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML , 1991, Cell.

[39]  J. Rottman,et al.  A retinoic acid-responsive element in the apolipoprotein AI gene distinguishes between two different retinoic acid response pathways , 1991, Molecular and cellular biology.

[40]  P. Pelicci,et al.  Structure and origin of the acute promyelocytic leukemia myl/RAR alpha cDNA and characterization of its retinoid-binding and transactivation properties. , 1991, Oncogene.

[41]  E. Dmitrovsky,et al.  Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). , 1991, The New England journal of medicine.

[42]  R. Evans,et al.  Characterization of DNA binding and retinoic acid binding properties of retinoic acid receptor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[43]  C. Peschle,et al.  Two-step differentiation of AML-193 leukemic line: terminal maturation is induced by positive interaction of retinoic acid with granulocyte colony-stimulating factor (CSF) and vitamin D3 with monocyte CSF. , 1991, Blood.

[44]  H. Dombret,et al.  Treatment of first relapse in acute promyelocytic leukaemia with all-trans retinoic acid , 1990, The Lancet.

[45]  P. Pandolfi,et al.  Rearrangements and aberrant expression of the retinoic acid receptor alpha gene in acute promyelocytic leukemias , 1990, The Journal of experimental medicine.

[46]  R Berger,et al.  All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. , 1990, Blood.

[47]  P. Fenaux,et al.  All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: structure-function relationship. , 1990, Blood.

[48]  R. Blomhoff,et al.  Transport and storage of vitamin A , 1990, Science.

[49]  Christine Chomienne,et al.  The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locus , 1990, Nature.

[50]  R. Momparler,et al.  Effect of 5-aza-2'-deoxycytidine and retinoic acid on differentiation and c-myc expression in HL-60 myeloid leukemic cells. , 1990, Cancer letters.

[51]  D. Sheer,et al.  Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. , 1990, Science.

[52]  V. Giguère,et al.  Molecular cloning of cDNA encoding a second cellular retinoic acid-binding protein. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[53]  T. Barbui,et al.  Early deaths and anti-hemorrhagic treatments in acute promyelocytic leukemia. A GIMEMA retrospective study in 268 consecutive patients. , 1990, Blood.

[54]  R. Evans,et al.  Nuclear receptor that identifies a novel retinoic acid response pathway , 1990, Nature.

[55]  S. Collins,et al.  Retinoic acid-induced granulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the retinoic acid receptor (RAR-alpha) , 1990, Molecular and cellular biology.

[56]  H. Stunnenberg,et al.  Identification of a retinoic acid responsive element in the retinoic acid receptor & beta;gene , 1990, Nature.

[57]  P. Chambon,et al.  A third human retinoic acid receptor, hRAR-gamma. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[58]  P. Chambon,et al.  Cloning of murine α and β retinoic acid receptors and a novel receptor γ predominantly expressed in skin , 1989, Nature.

[59]  G. Eichele,et al.  Molecular approaches to vertebrate limb morphogenesis. , 1989, Development.

[60]  B. Clarkson,et al.  Acute promyelocytic leukemia: treatment results during a decade at Memorial Hospital. , 1989, Blood.

[61]  L. Gudas,et al.  Mouse cellular retinoic acid binding protein: cloning, complementary DNA sequence, and messenger RNA expression during the retinoic acid-induced differentiation of F9 wild type and RA-3-10 mutant teratocarcinoma cells. , 1989, Cancer research.

[62]  P. Chambon,et al.  Nuclear receptors enhance our understanding of transcription regulation. , 1988, Trends in genetics : TIG.

[63]  D. Summerbell,et al.  Spatial distribution of cellular protein binding to retinoic acid in the chick limb bud , 1988, Nature.

[64]  Zhen-yi Wang,et al.  Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. , 1988, Haematology and blood transfusion.

[65]  R. Tarone,et al.  Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. , 1988, The New England journal of medicine.

[66]  R. Evans,et al.  The steroid and thyroid hormone receptor superfamily. , 1988, Science.

[67]  P. Chambon,et al.  Identification of a second human retinoic acid receptor , 1988, Nature.

[68]  Pierre Chambon,et al.  A human retinoic acid receptor which belongs to the family of nuclear receptors , 1987, Nature.

[69]  V. Giguère,et al.  Identification of a receptor for the morphogen retinoic acid , 1987, Nature.

[70]  H. Kagechika,et al.  New benzoic acid derivatives with retinoid activity: lack of direct correlation between biological activity and binding to cellular retinoic acid binding protein. , 1987, Cancer research.

[71]  J. Voorhees,et al.  Hypervitaminosis A syndrome: a paradigm of retinoid side effects. , 1987, Journal of the American Academy of Dermatology.

[72]  A. Tobler,et al.  Retinoids. Structure-function relationship in normal and leukemic hematopoiesis in vitro. , 1986, The Journal of clinical investigation.

[73]  E. Estey,et al.  Acute promyelocytic leukemia. M.D. Anderson Hospital experience. , 1986, The American journal of medicine.

[74]  E. Vellenga,et al.  Retinoic acid as antileukemic therapy in a patient with acute promyelocytic leukemia and Aspergillus pneumonia. , 1986, Blood.

[75]  J. Fontana,et al.  The role of 13 cis‐retinoic acid in the remission induction of a patient with acute promyelocytic leukemia , 1986, Cancer.

[76]  H. Blumenthal,et al.  Effect of Meals on the Kinetics of Etretinate , 1985, Journal of clinical pharmacology.

[77]  J. L. Napoli,et al.  Metabolism of retinoic acid and retinol during differentiation of F9 embryonal carcinoma cells. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[78]  P. A. Peterson,et al.  The primary structure of bovine cellular retinoic acid-binding protein. , 1985, The Journal of biological chemistry.

[79]  G. S. Johnson,et al.  Retinoic acid-induced expression of tissue transglutaminase in human promyelocytic leukemia (HL-60) cells. , 1985, The Journal of biological chemistry.

[80]  B. Nilsson.  Probable in vivo induction of differentiation by retinoic acid of promyelocytes in acute promyelocytic leukaemia , 1984, British journal of haematology.

[81]  J. Rowley,et al.  Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemia. , 1984, The American journal of medicine.

[82]  R. Branda,et al.  Retinoic acid treatment of acute promyelocytic leukemia: in vitro and in vivo observations. , 1983, Blood.

[83]  M. Sporn,et al.  Structure-activity relationships of a new series of retinoidal benzoic acid derivatives as measured by induction of differentiation of murine F9 teratocarcinoma cells and human HL-60 promyelocytic leukemia cells. , 1983, Cancer research.

[84]  M. Sporn,et al.  Role of retinoids in differentiation and carcinogenesis. , 1983, Cancer research.

[85]  H. Koeffler,et al.  Retinoic acid. Inhibition of the clonal growth of human myeloid leukemia cells. , 1982, The Journal of clinical investigation.

[86]  H. Koeffler,et al.  Human myeloid leukemia cell lines: a review. , 1980, Blood.

[87]  M. Sporn,et al.  In vitro metabolism of retinoic acid in hamster intestine and liver. , 1979, The Journal of biological chemistry.

[88]  L. Sachs.  Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukaemia , 1978, Nature.

[89]  F. Chytil,et al.  Cellular retinoic acid-binding protein from rat testis. Purification and characterization. , 1978, The Journal of biological chemistry.

[90]  H. Gralnick,et al.  Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group , 1976, British journal of haematology.

[91]  S. Wolbach,et al.  TISSUE CHANGES FOLLOWING DEPRIVATION OF FAT-SOLUBLE A VITAMIN , 1925, The Journal of experimental medicine.

[92]  T. B. Osborne,et al.  THE RELATION OF GROWTH TO THE CHEMICAL CONSTITUENTS OF THE DIET , 1913 .

[93]  C. Chomienne,et al.  In vitro all-trans retinoic acid (ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remission induction by ATRA in acute promyelocytic leukemia. , 1994, Leukemia.

[94]  C. Costello,et al.  Response to trans-retinoic acid in an AMLM3 patient resistant to cis-retinoic acid. , 1991, Leukemia research.

[95]  R. Lotan,et al.  Nuclear receptors for retinoids: mediators of retinoid effects on normal and malignant cells. , 1991, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[96]  X. Thomas,et al.  Prognostic Factors in Acute Promyelocytic Leukemia: A Retrospective Study of 67 Cases. , 1991, Leukemia & lymphoma.

[97]  P. Chambon,et al.  Retinoic acid receptors and cellular retinoid binding proteins. II. Their differential pattern of transcription during early morphogenesis in mouse embryos. , 1991, Development.

[98]  M. Rocher,et al.  Biological activity of retinoids correlates with affinity for nuclear receptors but not for cytosolic binding protein. , 1988, Skin pharmacology : the official journal of the Skin Pharmacology Society.

[99]  J. Halgunset,et al.  Subcellular concentrations of calcium, zinc, and magnesium in benign nodular hyperplasia of the human prostate: X-ray microanalysis of freeze-dried cryosections. , 1987, Cancer research.

[100]  M. Haussler,et al.  cis-Retinoic acid stimulates the clonal growth of some myeloid leukemia cells in vitro. , 1987, Blood.